New pre-clinical SHIV remission study shows progress in delaying viral load rebound
by The U.S. Military HIV Research Program (MHRP) Image Credit: CC0 Public Domain A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected macaques after antiretroviral therapy (ART) interruption. The experimental combination therapy consisted…
English
Nederlands
Français
Deutsch
Italiano
Português
Español